Additionally, brain metastases (BMs) occur in 40–50% of patients with advanced NSCLC [5], particularly in those with epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) oncogene mutations [6]. This evidence concerns the gene ALK and burning mouth syndrome.